Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn More
Alfa Cytology, a leading provider of cutting-edge solutions, presents its unparalleled cell surface immunophenotype analysis services, an indispensable resource for advancing leukemia research. Delving into the intricacies of immunophenotypic analysis, we unlock the potential to discriminate between myeloid and lymphocytic leukemia. Engage our exceptional team of seasoned experts, who will deftly navigate the labyrinthine landscape of leukemia immunophenotyping, crafting a bespoke plan tailored to your unique requisites.
Utilizing fluorescently labeled antibodies, flow cytometry emerges as a prevalent technique for examining the expression of cell surface markers. This technique enables the precise identification and quantification of specific cell populations based on their immunophenotype. When applied to the analysis of leukemic cells, flow cytometry serves as a highly effective approach for discerning tumor lineage. Accurate lineage identification assumes utmost significance in the realms of diagnosis, differential diagnosis, prognosis, and treatment selection.
Fig. 1. B lymphoblastic leukemia, typical immunophenotype. (DiGiuseppe, J.A. Wood, B.L., 2019)
Immunophenotyping is a test that identifies cells based on the type of markers or antigens present on the cell surface, nucleus, or cytoplasm. It is widely used to diagnose different types of lymphomas and leukemias by comparing normal cells with cancer cells. Alfa Cytology provides comprehensive peptide vaccine development services, including but not limited to the following.
We provide flow cytometry and immunocytochemistry-based assay development for immunophenotyping of leukemia to accurately detect and quantify leukemic cells. Our proprietary antibodies, specifically developed and validated for recognizing leukemia-specific antigens, are utilized in both flow cytometry and immunocytochemistry assays. These techniques enable the identification of distinct cell populations within blood and other lymphoid tissues.
We provide a diverse range of flow cytometry options for analyzing cell immunophenotypes and identifying various types of leukemia. These comprehensive solutions offer valuable research methods to support your investigations.
| Technologies | Service Details |
| Conventional flow cytometry | We offer conventional flow cytometry services for the detection of leukemic cells and identification of CD on their surface, facilitating immunophenotypic analysis. |
| Imaging flow cytometry | Our imaging flow cytometry technology enables the analysis of leukemia cell phenotype from multiple perspectives by providing both cell morphology and surface antigen information. |
| Multicolor flow cytometry | The multicolor flow cytometry developed for leukemia monitoring exhibits high specificity and sensitivity. It allows for the definition of the cellular lineage and identification of phenotypic aberrations, making it suitable for evaluating minimal residual disease. |
Our organization provides specialized services for the development of immunohistochemistry-based assays, catering to your interest in studying the organization and expression patterns of distinct proteins. Our Immunohistochemistry services provide valuable insights into cell participation patterns and cytological characteristics that go beyond the capabilities of flow cytometry, offering additional information for your research needs.
Alongside our range of immunophenotypic analysis methods, we offer customized solutions tailored to your specific requirements. If you are seeking to develop a novel method for determining the immunophenotype of leukemia, we provide innovative insights and advanced technical support to assist you in this endeavor.
Alfa Cytology is your trusted partner for immunophenotypic analysis of leukemia. We are committed to delivering accurate, reliable, and actionable results to accelerate your research. Contact us to discuss your specific research needs and discover how our immunophenotypic analysis services can support your leukemia research.
Reference